These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1239 related items for PubMed ID: 9539559
21. Efficacy of neoadjuvant chemoradiotherapy in resectable esophageal squamous cell carcinoma--a single institutional study. Lee JL, Kim SB, Jung HY, Park SI, Kim DK, Kim JH, Song HY, Kim WK, Lee JS, Min YI. Acta Oncol; 2003; 42(3):207-17. PubMed ID: 12852697 [Abstract] [Full Text] [Related]
22. Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data. Koo DH, Park SI, Kim YH, Kim JH, Jung HY, Lee GH, Choi KD, Song HJ, Song HY, Shin JH, Cho KJ, Yoon DH, Kim SB. Cancer Chemother Pharmacol; 2012 Mar; 69(3):655-63. PubMed ID: 21968953 [Abstract] [Full Text] [Related]
23. Comparison between chemoradiation protocol intended for organ preservation and conventional surgery for clinical T1-T2 esophageal carcinoma. Murakami M, Kuroda Y, Nakajima T, Okamoto Y, Mizowaki T, Kusumi F, Hajiro K, Nishimura S, Matsusue S, Takeda H. Int J Radiat Oncol Biol Phys; 1999 Sep 01; 45(2):277-84. PubMed ID: 10487546 [Abstract] [Full Text] [Related]
29. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma. Kato K, Nakajima TE, Ito Y, Katada C, Ishiyama H, Tokunaga SY, Tanaka M, Hironaka S, Hashimoto T, Ura T, Kodaira T, Yoshimura K. Jpn J Clin Oncol; 2013 Jun 01; 43(6):608-15. PubMed ID: 23585687 [Abstract] [Full Text] [Related]
30. Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy-followed-by-esophagectomy for T4 esophageal cancers. Fujita H, Sueyoshi S, Tanaka T, Tanaka Y, Sasahara H, Shirouzu K, Suzuki G, Hayabuchi N, Inutsuka H. J Surg Oncol; 2005 Jun 15; 90(4):209-19. PubMed ID: 15906363 [Abstract] [Full Text] [Related]
31. First-line chemotherapy improves the resection rate and long-term survival of locally advanced (T4, any N, M0) squamous cell carcinoma of the thoracic esophagus: final report on 163 consecutive patients with 5-year follow-up. Ancona E, Ruol A, Castoro C, Chiarion-Sileni V, Merigliano S, Santi S, Bonavina L, Peracchia A. Ann Surg; 1997 Dec 15; 226(6):714-23; discussion 723-4. PubMed ID: 9409570 [Abstract] [Full Text] [Related]
33. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516). Ishida K, Ando N, Yamamoto S, Ide H, Shinoda M. Jpn J Clin Oncol; 2004 Oct 15; 34(10):615-9. PubMed ID: 15591460 [Abstract] [Full Text] [Related]